forgemax.FORGED. TESTED. PROVEN.
Nandrolone Decanoate 200mg/ml 10x1ml Ampullen by Pharm-Tec
HPLC Verified

Nandrolone Decanoate 200mg/ml 10x1ml Ampullen by Pharm-Tec

Pharm-Tec Nandrolone Decanoate 200mg/ml delivers the long-acting 19-nor anabolic in single-dose 1ml ampoules engineered for athletes who build SARM-anchored stacks requiring a low-aromatising injectable base with predictable depot behaviour. Its 200mg/ml concentration makes weekly volume management straightforward when co-administering tissue-selective SARM compounds that operate on overlapping but non-identical receptor pathways. Batch potency is confirmed by HPLC assay; each ampoule exits the production line only after meeting pharmaceutical-grade sterility criteria — no multi-dose compromise, no preservative carry-over.

€48.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Provides a systemic AR-active injectable base that tissue-selective SARMs cannot replicate alone
  • 200mg/ml concentration delivers a clean 0.75–1.0ml weekly injection volume in SARM stacking contexts
  • Single-dose 1ml ampoule format guarantees per-dose sterility across extended 12–16 week cycles
  • HPLC-verified batch potency ensures the labelled 200mg/ml is what reaches systemic circulation
  • 19-nor structure results in substantially lower aromatisation than testosterone, reducing oestrogen management complexity in SARM protocols
  • Decanoate ester sustains plasma nandrolone levels across a 7-day injection interval without requiring twice-weekly administration
  • Collagen and erythropoietic tissue coverage extends anabolic benefit beyond myocyte hypertrophy alone

Key takeaways

  • Pair Nandrolone Decanoate 200mg/ml with SARMs for complementary dual-pathway anabolic coverage.
  • Monitor serum prolactin closely throughout any 19-nor compound and SARM combination.
  • Use single-dose ampoules to eliminate repeated-puncture contamination across long cycles.
  • Titrate Nandrolone Decanoate in 1ml increments when adjusting a SARM stack dose.
  • Confirm batch potency via HPLC documentation before initiating any multi-compound protocol.

Nandrolone Decanoate as the Injectable Foundation of a SARM-Enhanced Stack

Pharm-Tec Nandrolone Decanoate 200mg/ml is a depot-injectable 19-nor anabolic compound whose primary application, in the context of modern evidence-informed stacking, is to serve as the androgen-receptor base layer beneath selective androgen receptor modulators (SARMs) that lack the collagen-supportive and erythropoietic breadth of a full steroidal androgen. Nandrolone Decanoate occupies systemic androgen receptors in muscle and connective tissue, while SARMs such as Ostarine (MK-2866), LGD-4033, or RAD-140 act on a narrower, tissue-preferential receptor subset — creating complementary rather than redundant anabolic coverage.

Why SARMs and Nandrolone Decanoate Cover Different Receptor Territories

SARMs are engineered for tissue selectivity, preferentially activating androgen receptors in skeletal muscle while limiting prostate and sebaceous engagement. Nandrolone Decanoate, by contrast, stimulates androgen receptors across a broader tissue distribution — including bone matrix and synovial fibroblasts — delivering structural support that orally bioavailable SARMs cannot replicate. Compared to stacking two full anabolic steroids, a Nandrolone Decanoate–SARM combination produces substantially less total androgenic burden, which makes it an analytically distinct protocol category rather than a variation on conventional polypharmacy.

Mechanistic Rationale for the Combination

Nandrolone Decanoate upregulates local IGF-1 transcription through androgen response element binding, as confirmed by in-vitro myocyte studies published in peer-reviewed endocrinology journals. SARMs such as LGD-4033 independently activate downstream mTOR signalling measured by phospho-S6K1 assay in clinical-phase pharmacology data. The two pathways converge on lean-tissue accrual through mechanistically distinct entry points — AR-transcriptional versus AR-conformational signalling — supporting the hypothesis that the combination yields additive lean-mass output at lower aggregate milligram loading than doubling either compound alone.

Dosing Geometry in a SARM Stack Context

At 200mg/ml, a 150–200mg weekly Nandrolone Decanoate dose occupies exactly 0.75–1.0ml per injection — a volume that pairs cleanly with oral SARM administration without forcing large-gauge multi-compound injection volumes. Each 1ml single-dose ampoule provides one complete weekly dose at the lower end of the SARM-combination range, allowing athletes to titrate upward by one ampoule increments while tracking lean-mass response via DEXA or skinfold caliper protocols.

Quality Infrastructure: HPLC Verification and Single-Dose Ampoule Integrity

Pharm-Tec subjects each production batch to HPLC potency analysis, confirming active nandrolone content within pharmaceutical tolerance before distribution. The 10×1ml ampoule format eliminates the repeated-puncture sterility risk inherent to multi-dose vials — a meaningful advantage in longer SARM cycles where Nandrolone Decanoate may run 12–16 weeks continuously.

Usage

  1. Confirm SARM tolerability first: run your chosen SARM solo for at least two weeks and obtain a baseline prolactin, LH, FSH, testosterone, haematocrit, ALT, and AST panel before introducing Nandrolone Decanoate.
  2. Select your weekly Nandrolone Decanoate dose within the SARM-combination range (150–200mg/week = 0.75–1.0ml); snap open one 1ml ampoule per injection day using the ampoule neck score.
  3. Draw the oil solution using an 18-gauge drawing needle to minimise particulate risk, then switch to a 23–25 gauge injection needle for intramuscular administration into the glute or lateral quadriceps.
  4. Administer Nandrolone Decanoate on a fixed weekly day (e.g. every Monday) to maintain predictable depot accumulation; take your SARM orally on the same daily schedule irrespective of injection timing.
  5. Run mid-cycle bloodwork at week 6–8: if serum prolactin exceeds the upper reference limit, introduce cabergoline at 0.25mg twice weekly; if haematocrit rises above 52%, consult a physician before continuing.
  6. Dispose of each opened ampoule immediately after use in an appropriate sharps container — single-dose ampoules are never to be re-capped or stored partially used.

Warnings

Contraindications: Nandrolone Decanoate is contraindicated in individuals with prostate carcinoma, breast carcinoma, or nephrotic-stage renal disease. Hypersensitivity to nandrolone, sesame or arachis oil carriers, or benzyl alcohol excipients precludes use. Females of childbearing potential should not use this compound due to virilisation risk. SARM combination does not eliminate these contraindications.

Side Effects: Prolactin elevation is the primary 19-nor-specific endocrine risk — more pronounced than with testosterone alone and potentially compounded by certain SARMs. Mild-to-moderate suppression of LH and FSH occurs within the first four weeks at 200mg/week. Androgenic effects (acne, accelerated scalp hair recession in genetically predisposed individuals) are lower than with testosterone but not absent. Haematocrit elevation is possible with longer cycles; monitor via full blood count.

Monitoring: Mandatory panel at baseline, week 6–8 (mid-cycle), and week 4 post-cycle: serum total testosterone, LH, FSH, prolactin, oestradiol, haematocrit, ALT, AST, and lipid profile. SARM co-administration adds hepatic enzyme monitoring as several SARMs demonstrate measurable ALT elevations in Phase I pharmacokinetic studies. Cabergoline (0.25–0.5mg twice weekly) should be available as a prolactin management tool before cycle commencement.

PCT: Because Nandrolone Decanoate suppresses the hypothalamic-pituitary axis through androgen receptor-mediated negative feedback, a SERM-based PCT (clomiphene or tamoxifen) is required after cycle completion. PCT should not commence until at least 21 days after the final injection to account for the decanoate ester's extended clearance window. SARM-specific HPTA impact should be factored into PCT duration — combined suppression may require a full 6–8 week recovery protocol rather than the 4-week minimum.

Frequently asked questions

Can Nandrolone Decanoate 200mg/ml be combined with SARMs in the same cycle?
Yes — Nandrolone Decanoate serves as a broad-spectrum injectable androgen base while SARMs provide tissue-selective AR activation on a narrower receptor subset. The combination targets lean-tissue accrual through two mechanistically distinct pathways simultaneously. Most practitioners keep Nandrolone Decanoate at 150–200mg per week when combining with a SARM to manage total androgenic load, verified by serum testosterone and haematocrit monitoring.
Which specific SARMs are most commonly paired with Nandrolone Decanoate in bodybuilding protocols?
Ostarine (MK-2866) at 25mg daily and LGD-4033 at 10mg daily are the most frequently reported SARM partners for Nandrolone Decanoate in community survey data and case-report literature. RAD-140 is occasionally substituted when greater androgenic stimulus is targeted. The rationale across all three choices is identical: the SARM handles tissue-selective anabolic signalling while Nandrolone Decanoate delivers systemic connective-tissue and erythropoietic support.
What monitoring parameters are essential when running a Nandrolone Decanoate and SARM combination stack?
Serum prolactin must be tracked because Nandrolone Decanoate, as a 19-nor compound, can elevate prolactin in a dose-correlated pattern; add cabergoline if prolactin rises above the upper reference range. Liver enzymes (ALT, AST) should be checked mid-cycle because several SARMs carry measurable hepatotoxicity risk measured in Phase I clinical pharmacology trials. Total testosterone, LH, FSH, and haematocrit complete the panel.
How does the single-dose 1ml ampoule format benefit athletes on long SARM cycles?
Each Pharm-Tec 1ml ampoule is sealed at the point of manufacture and opened once — eliminating cumulative contamination risk that multi-dose vials accumulate across repeated septum punctures during a 12–16 week SARM cycle. There is no antimicrobial preservative required, which avoids the rare preservative-related injection-site reactions reported with benzyl-alcohol-preserved multi-dose presentations. Sterility integrity is factory-guaranteed for every individual dose.
How should Pharm-Tec Nandrolone Decanoate 200mg/ml ampoules be stored to preserve potency across a full cycle?
Store unopened ampoules between 15–25°C, away from direct light and moisture, in their original carton. Avoid refrigeration, which can cause the oil carrier to cloud temporarily — a reversible physical change that does not affect potency but may complicate precise drawing. Each ampoule is a single-use unit; once snapped open, the contents should be drawn and injected immediately. HPLC-verified potency is guaranteed only for sealed, correctly stored ampoules. (2) angle_used

Manufacturer

Pharm-Tec's product portfolio is built around a curated range of injectable anabolic preparations spanning several major active-ingredient classes — testosterone esters, 19-nor compounds, and ancillary injectables — each sourced and distributed under consistent quality-control parameters. Within the Nandrolone segment specifically, Pharm-Tec's offering is differentiated by its 10×1ml single-dose ampoule format: a presentation chosen not for volume economies but for per-dose sterility assurance across multi-week cycles. The company's quality infrastructure includes HPLC batch verification as a release requirement, meaning no Nandrolone Decanoate ampoule enters the distribution chain without documented potency confirmation against the 200mg/ml label specification. This portfolio philosophy — moderate concentration, single-dose format, verified potency — positions Pharm-Tec's injectable line toward athletes who prioritise measurable accuracy over high-concentration convenience.

Product details

BrandPharm-Tec
Active ingredientnandrolone decanoate
Also known asDeca Durabolin, Deca, Nandrolone Decanoate, Nandrolonee Decanoatee, Pharm-Tec Deca Durabolin
Strength200 mg
FormAmpullen
Pack size10 pieces
Item numberINJ-NAND-PHA-200-021

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Decandrol 200mg/ml 10x1ml Ampoules by Balkan PharmaceuticalsEstablished Brand

Decandrol 200mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

€44.00
Deca-Durabolin 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Deca-Durabolin 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€52.00
Decadubol-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Decadubol-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€45.00
DecaTrex 350mg/ml 10ml Vial by Concentrex LabsTrusted Brand

DecaTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00